Short-term and Oncological Outcomes of Laparoscopic Colorectal Cancer Surgery in Obese Patients

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04716062

Acronym

Surg_2021

Enrollment

138

Registered

2021-01-20

Start date

2018-01-01

Completion date

2020-12-31

Last updated

2021-01-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer, Obesity

Brief summary

A total of 138 consecutive patients who underwent laparoscopic-assisted or open colectomy for colorectal cancer (CRC) were included in the present study. Subjects commonly shared a condition of overweight or obesity. The investigators aimed to define any difference between the two different groups (open vs laparoscopic-assisted surgery) and a series of outcomes, i.e. hospitalization, Lymph nodes number, Intra-Surgery complications, and Clavien Dindo score.

Detailed description

A total of 138 consecutive patients who underwent laparoscopic-assisted or open colectomy for colorectal cancer (CRC) were included in the present study. Intra-Surgery complications, Previous surgery, Readmission Post Intervention, Location of surgery, Duration of Surgery, Re-intervention (yes), Clearance, and CRM were collected. Subjects commonly shared overweight or obesity. The investigators aimed to define any difference between the two different groups (open vs laparoscopic-assisted surgery) and a series of outcomes, i.e. hospitalization, Lymph nodes number, Intra-Surgery complications, and Clavien Dindo score.

Interventions

PROCEDUREOpen or Laparoscopic-assisted Colorectal surgery

Colorectal surgery

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 90 Years

Inclusion criteria

* Body mass index \>25 Kg/m2 * Colorectal cancer (CRC)

Exclusion criteria

* Current emergency conditions (i.e., perforation and\\or occlusion) * Pregnancy, * Co-existing peritoneal carcinomatosis * Contraindications to LS, such as cardiorespiratory comorbidities (CHD, CHF, and other severe CVD) * Prior transverse resections

Design outcomes

Primary

Measure	Time frame	Description
Hospitalization	baseline	days
Lymph Nodes number	baseline	Lymph Nodes number
Clavien Dindo score (post-operative complications)	baseline	1 to 5 point

Secondary

Measure	Time frame	Description
Age	Baseline	years
Body mass index	Baseline	Kilograms/m2
Lenght of specimen	Baseline	centimeters

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026